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Abstract
Extremely low-frequency magnetic fields (ELF-MFs) are generated by power lines and
household electrical devices. In the last several decades, some evidence has shown an
association between ELF-MF exposure and depression and/or anxiety in epidemiological
and animal studies. The mechanism underlying ELF-MF-induced depression is considered
to involve adrenal steroidogenesis, which is triggered by ELF-MF exposure. However, how
ELF-MFs stimulate adrenal steroidogenesis is controversial. In the current study, we investi-
gated the effect of ELF-MF exposure on the mouse adrenal cortex-derived Y-1 cell line and
the human adrenal cortex-derived H295R cell line to clarify whether the ELF-MF stimulates
adrenal steroidogenesis directly. ELF-MF exposure was found to significantly stimulate
adrenal steroidogenesis (p < 0.01–0.05) and the expression of adrenal steroid synthetic
enzymes (p < 0.05) in Y-1 cells, but the effect was weak in H295R cells. Y-1 cells exposed
to an ELF-MF showed significant decreases in phosphodiesterase activity (p < 0.05) and
intracellular Ca2+ concentration (p < 0.01) and significant increases in intracellular cyclic
adenosine monophosphate (cAMP) concentration (p < 0.001–0.05) and cAMP response
element-binding protein phosphorylation (p < 0.05). The increase in cAMP was not inhibited
by treatment with NF449, an inhibitor of the Gs alpha subunit of G protein. Our results sug-
gest that ELF-MF exposure stimulates adrenal steroidogenesis via an increase in intracellu-
lar cAMP caused by the inhibition of phosphodiesterase activity in Y-1 cells. The same
mechanism may trigger the increase in adrenal steroid secretion in mice observed in our
previous study.
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Introduction
Exposure to extremely low-frequency magnetic fields (ELF-MFs), which are mainly generated
by power lines and household electrical devices, has increased in modern society. Multiple
studies using cell lines, animal models, and human subjects and also epidemiological studies
have investigated whether ELF-MFs have biological effects; however, the effects remain contro-
versial [1–3]. In the last several decades, an association between ELF-MF exposure and depres-
sion and/or anxiety has been reported in epidemiological [4, 5] and animal studies [6, 7]. Early
animal studies also reported a relationship between ELF-MF-induced depressive behavior and
adrenal steroid secretion, and the mechanism of adrenal steroidogenesis is assumed to involve
induction of a common stress response resulting from ELF-MF exposure [7, 8].
We previously reported that chronic ELF-MF exposure affects corticosterone synthesis and
depression-like behavior without enhancement of the hypothalamic–pituitary–adrenal axis in
mice [9]. This result suggests that ELF-MF stimulates steroidogenesis in the adrenal cortex
directly, and not via the common stress response. However, the mechanism underlying
ELF-MF-triggered steroidogenesis is not known at present.
In this study, we first investigated the effect of ELF-MF exposure on the mouse adrenal cor-
tex-derived Y-1 cell line to clarify whether ELF-MF stimulates adrenal steroidogenesis directly.
We found that adrenal steroidogenesis was enhanced in Y-1 cells by ELF-MF exposure. Addi-
tionally, we investigated the mechanism underlying the steroidogenesis. The possibility of an
effect on humans was estimated using the adrenal cortex-derived H295R cell line; no effects
were observed in these cells. Our results showed that the ELF-MF directly stimulated steroido-
genesis in the adrenal cortex and not via the common stress response in the mouse adrenal cell
line.
Materials and Methods
Cell culture
The mouse adrenal cortex-derived Y-1 cell line (RBRC-RCB533; provided by RIKEN BRC
through the National Bio-Resource Project of the MEXT, Tsukuba, Japan) and the human
adrenal cortex-derived H295R cell line (ATCC CRL-2128; provided by American Type Culture
Collection, Manassas, VA, USA) were used. The cells were cultured in 35-mm diameter culture
dishes. Y-1 cells were seeded in RPMI 1640 medium + 10% fetal bovine serum at a density of
2 × 105 cells/dish and incubated at 37 ± 0.5°C in a 5% CO2 humidified atmosphere for 4 days.
H295R cells were seeded in DMEM:F12 medium + 2.5% Nu-serum I and 1% ITS+mix (BD
Biosciences, Bedford, MA, USA) at density of 8 × 105 cells/dish and incubated at 37 ± 0.5°C in
a 5% CO2 humidified atmosphere for 4 days.
ELF-MF exposure
Confluency was achieved after the 4-day incubation. Then, the cell dishes in the ELF-MF
group were exposed to a 60-Hz ELF-MF for 1–48 h by using a custom-made exposure appara-
tus after medium replacement. In the sham control group, sham exposure was performed
simultaneously with the ELF-MF exposure using a sham apparatus, which was made using the
same materials with the same size, except for the coil. Details regarding the ELF-MF and sham
exposure apparatuses have been provided in a previous study [10]. In brief, each exposure
apparatus consisted of a cylindrical plastic (polyvinyl chloride) container (37 cm outer diame-
ter; 34.5 cm inner diameter; 33 cm length) placed vertically. In the ELF-MF exposure appara-
tus, the coil consisted of one primary coil and two secondary coils that were placed on the
upper and lower ends of the primary coil. The coils were made of enameled wires (2.12 mm
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diameter, electric resistance 5.66 O/km). For the primary coil, the wire was wound 150 times
around the plastic container. For the two secondary coils, the wire was wound 33 times around
every layer to correct the uneven distribution of the magnetic flux density of the primary coil.
A plastic incubator (25-cm length, 20-cm width, and 10-cm height) containing the culture
dishes was placed in the middle of each plastic container. To maintain a temperature of
37 ± 0.5°C in a 5% CO2 atmosphere in the incubator, warm water (40 ± 0.5°C) and 5% CO2 air
were supplied in the container. The temperature difference between ELF-MF and sham expo-
sure apparatuses was maintained within ± 0.5°C by the flow of warm water in each apparatus.
To maintain humidity, distilled water was arranged in the incubator. The base values of the
ELF-MF and static MF in the ELF-MF and sham exposure apparatuses were 40–50 μT and 25–
30 μT, respectively. The intensity of the ELF-MF was set between 0.25 and 3 mT. The intensity
of MF was measured using a gaussmeter (type 501; Nihon Denji Sokki, Tokyo, Japan). After
exposure, the medium and cells were sampled and used for subsequent analysis.
Adrenal steroid quantification
Adrenal steroids (corticosterone, aldosterone, and cortisol) secreted in the medium were quan-
tified using ELISA kits (500655, 10004377, 500360, respectively; Cayman Chemical; Ann
Arbor, MI, USA). The value was standardized (/105 cells) according to the cell count, which
was estimated by C-Chip (DHC-B02; NanoEnTek, Seoul, Korea), in each sampled dish. The
experiments were performed according to the manufacturer’s instructions. Steroids were quan-
tified twice per sample and the data were averaged.
Real-time reverse transcription polymerase chain reaction (qRT-PCR)
mRNA extraction and subsequent two-step qRT-PCR analysis were performed as reported previ-
ously [9]. Briefly, total RNA was extracted from the cells of each dish with ISOGEN reagent
(Nippon Gene, Toyama, Japan). Reverse transcription of total RNA was performed using a Tran-
scriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany). The cDNA
was quantified using Universal ProbeLibrary probes (Roche Diagnostics) and a Prism 7500 appa-
ratus (Applied Biosystems, Foster, CA). The PCR program was as follows: 10 min pre-heating at
95°C and 55 cycles at 94°C for 30 s, 57°C for 30 s, and 72°C for 45 s. Expression of glyceralde-
hyde-3-phosphate dehydrogenase (Gapdh) was used as an endogenous control for quantification
of the mRNA targets (threshold cycle (Ct) of target expression/Ct ofGapdh expression). The tar-
get genes, Universal ProbeLibrary probe numbers, and primer sequences used in this study are
shown in Table 1. Quantification was performed once for each sample and gene target.
Western blotting
Protein extraction and subsequent protein expression analysis were performed as described
previously [11]. The cells were lysed using RIPA buffer mixed with protease inhibitor and
phosphatase inhibitor (EzRIPA Lysis kit; Atto, Tokyo, Japan). Supernatant-derived protein
samples (10 mg of protein per sample) were electrophoresed on a 2–20% sodium dodecyl sul-
phate polyacrylamide gel and transferred to a polyvinylidene difluoride membrane (Clearblot
P membrane; Atto, Tokyo, Japan). The membrane was blocked in blocking reagent (EzBlock;
Atto) at room temperature for 30 min and incubated sequentially (4°C, overnight, each incuba-
tion) with mouse polyclonal antibodies (1:5000 dilution) against StAR (#8449; Cell Signaling
Technology, Danvers, MA, USA), CYP11A1 (#12491; Cell Signaling Technology), CYP11B2
(SAB1303149; Sigma-Aldrich, St. Louis, MO, USA), CYP17A1, total cAMP response element-
binding protein (CREB) (#9197, Cell Signaling Technology), phospho-CREB (#9198, Cell Sig-
naling Technology), and actin (A2066; Sigma-Aldrich), followed by a 1-h incubation with a
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horseradish-peroxidase-conjugated sheep antibody against rabbit IgG (A602PN, 1:20,000 dilu-
tion; American Qualex, San Clemente, CA, USA). The CYP17A1 antibody was kindly provided
by Dr. Kazunori Ishimura (Professor Emeritus, Tokushima University). Immunoreactive pro-
tein bands were developed using a chemiluminescent HRP substrate (Immobilon Western;
Millipore, Billerica, MA, USA). The bands were scanned and analyzed using a computer-based
image analyzer (LAS-3000UVmini; Fujifilm, Tokyo, Japan). The intensity of the bands corre-
sponding to each sample was normalized to that of the band corresponding to actin for enzyme
expression. For analysis of CREB phosphorylation, the intensity was normalized to total CREB
expression. Each sample and protein target was analyzed once.
Cyclic adenosine monophosphate (cAMP) quantification
Intracellular cAMP was quantified using an ELISA kit (581001; Cayman Chemical). The value
was standardized to the amount of total protein in each extract, which was estimated using the
Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). The experi-
ments were performed according to the manufacturer’s instructions. cAMP was quantified
twice per sample, and the data were averaged.
Table 1. Genes quantified in this study, along with the corresponding primer sequences and probe numbers from the Universal ProbeLibrary.
Gene NCBI RefSeq
number
Sense
base
numbers
Sense sequence Universal
ProbeLibrary
Antisense
base
numbers
Antisense sequence
Mouse steroidogenic
acute regulatory protein
(Star)
NM_011485.4 765–786 5'-aaactcacttggctgctcagta-3' #83 819–838 5'-tgcgataggacctggttgat-3'
Mouse cytochrome P450,
family 11, subfamily a,
polypeptide 1 (Cyp11a1)
NM_019779.3 1381–1398 5'-gggtgttcggcagtgtct-3' #78 1468–1489 5'-cacatcacggagattttgaact-3'
Mouse cytochrome P450,
family 11, subfamily b,
polypeptide 1 (Cyp11b1)
NM_001033229.2 708–729 5'-aaaccaccacacagctcttgta-3' #92 812–836 5'-acacattcttgatacatttggtgac-3'
Mouse cytochrome P450,
family 11, subfamily b,
polypeptide 2 (Cyp11b2)
NM_009991.3 267–285 5'-gcagggccaagaaaaccta-3' #80 329–348 5'-tttccctacactgtgcctga-3'
Mouse glyceraldehyde-
3-phosphate
dehydrogenase (Gapdh)
NM_008084.2 763–781 5'-tgtccgtcgtggatctgac-3' #80 818–837 5'-cctgcttcaccaccttcttg-3'
Human steroidogenic
acute regulatory protein
(Star)
NM_000349.2 307–325 5'-agacacatgcgcaacatga-3' #17 396–415 5'-ggttaatccacgtgctaggg-3'
Human cytochrome P450,
family 11, subfamily a,
polypeptide 1 (Cyp11a1)
NM_000781.2 559–580 5'-gacccataggagtcctgttgaa-3' #79 635–652 5'-ttcttggtggcctctgga-3'
Human cytochrome P450,
family 11, subfamily b,
polypeptide 1 (Cyp11b1)
NM_000497.3 519–538 5'-ccctgaagaagaaggtgctg-3' #26 606–625 5'-tccaaaaagagccaagttgc-3'
Human cytochrome P450,
family 11, subfamily b,
polypeptide 2 (Cyp11b2)
NM_000498.3 200–218 5'-tggagatgcaccagacctt-3' #17 242–261 5'-tggtcctcccaagttgtacc-3'
Human cytochrome P450,
family 17, subfamily a,
polypeptide 1 (Cyp17a1)
NM_000102.3 566–584 5'-tttgccctgttcaaggatg-3' #78 627–646 5'-ggccagcatatcacacaatg-3'
Human glyceraldehyde-
3-phosphate
dehydrogenase (Gapdh)
NM_002046.3 83–101 5'-agccacatcgctcagacac-3' #60 130–148 5'-gcccaatacgaccaaatcc-3'
doi:10.1371/journal.pone.0154167.t001
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NF449 treatment
NF449 (4, 4', 4'', 4‴- [carbonylbis[imino- 5, 1, 3- benzenetriylbis(carbonylimino)]]tetrakis- 1,
3- benzenedisulfonic acid; Cayman Chemical), an inhibitor of the Gsα subunit of G protein,
was dissolved in culture medium (10 or 30 μM). Normal culture medium was used for the vehi-
cle control. NF449 or vehicle control was added to the each culture dish before 6-h ELF-MF or
sham exposure. After exposure, the intracellular cAMP concentration was estimated.
Fura-2AM assay
The change in intracellular Ca2+ concentration ([Ca2+]i) in Y-1 cells was estimated using the
Fura-2AM kit (Calcium Kit-Fura2; DojindoMolecular Technologies, Kumamoto, Japan). Y-1
cells were seeded in RPMI 1640 medium + 10% fetal bovine serum at a density of 2 × 104 cells/
well in 96-well culture plates and incubated at 37 ± 0.5°C in a 5% CO2 humidified atmosphere
for 4 days. After pre-incubation and medium replacement, 24-h ELF-MF and sham exposure
were performed. Next, 5 μM Fura2-AM was added to each well for 1 h at 37 ± 0.5°C according to
the manufacturer’s instructions. Fluorescence analysis was performed with excitation wave-
lengths of 340 nm and 380 nm and an emission wavelength of 510 nm with a microplate reader
(Varioskan Flash; Thermo Fisher Scientific) in each well. The 340/380 nm emission ratio was
used for comparative assessment of [Ca2+]i. The Fura ratio was estimated once for each sample.
Phosphodiesterase (PDE) activity
Cells were lysed using RIPA buffer mixed with a protease inhibitor and a phosphatase inhibi-
tor. The supernatant was purified using chromatography columns (Micro Bio-Spin P-6; Bio-
Rad, Hercules, CA, USA). The PDE activity of the desalted samples was estimated using the
PDE activity assay kit (BML-AK800; Enzo Life Sciences, Farmingdale, NY, USA). The value
(amount of 5' AMP) was standardized to the amount of total protein, which was estimated
using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) in each sample. PDE quan-
tification was conducted twice per sample, and data were averaged.
Statistical analysis
Data have been provided as the mean ± standard error of the mean (S.E.M.). Repeated mea-
sures two-way analysis of variance was used to analyze the non-standardized sequential data
(steroids and cAMP concentration, and PDE activity). When ANOVA showed significance in
groups, post hoc Scheffe’s test was performed. An unpaired t-test was used to compare stan-
dardized sham and ELF-MF data (gene and protein expression, Fura2-AM assay, and ratios
relative to sham exposure for the intensity-dependent effect of ELF-MF exposure). Significance
was set at p< 0.05.
Results
Effects of ELF-MF exposure on adrenal steroid secretion and adrenal
enzyme expression
Fig 1 shows the effects of different periods of exposure to a 1.5-mT ELF-MF on adrenal steroid
secretion and the expression of adrenal enzymes in mouse adrenal Y-1 cells (n = 8 each). Corti-
costerone and aldosterone secretion increased until 24 h and was then reduced at 48 h of
ELF-MF and sham exposure. The change in steroid secretion over time was significant
(p< 0.0001). However, the levels after 6, 24, and 48 h of ELF-MF exposure were significantly
higher than those after sham treatment (Fig 1A and 1B).
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Next, we estimated the mRNA and protein expression of adrenal steroid synthetic enzymes
(StAR, CYP11A1, CYP11B1, and CYP11B2) to clarify the cause of the increase in adrenal ste-
roid levels after 24-h ELF-MF and sham exposure. StAR facilitates the movement of cholesterol
from the outer to the inner mitochondrial membrane [12]. CYP11A1 is a rate-limiting enzyme
for steroidogenesis [13] [14], and CYP11B1 and CYP11B2 convert 11-deoxycorticosterone to
corticosterone and aldosterone [15]. Cyp11a1 and Cyp11b2mRNA levels were significantly
higher after 24-h exposure to the ELF-MF than after 24-h sham exposure, whereas no differ-
ences were noted for Star and Cyp11b1mRNA (Fig 1C). At the protein level, a significant dif-
ference was noted only for CYP11A1 (Fig 1D).
The results for adrenal steroid secretion and adrenal enzyme expression in human adrenal
H295R cells (n = 8 each) after different periods of exposure to a 1.5-mT ELF-MF are summa-
rized in Fig 2. The levels of cortisol and aldosterone secretion were not significantly different
between sham and ELF-MF exposure (Fig 2A and 2B). The increase in steroid secretion overt
time was significant (p< 0.0001). mRNA expression of Star was significantly higher under the
ELF-MF than under sham exposure (Fig 2C), whereas differences for the other adrenal steroid
synthetic enzymes were not significant. No significant differences were found at the protein
level (Fig 2D).
Effects of ELF-MF exposure on cAMP concentration, CREB
phosphorylation, and [Ca2+]i
Next, we investigated the mechanism underlying the adrenal steroidogenesis induced by
ELF-MF exposure in Y-1 cells. Adrenal steroidogenesis is regulated by two signaling pathways:
Fig 1. Effects of ELF-MF and sham exposure on steroid secretion and enzyme expression in Y-1 cells. Data are presented as the mean ± S.E.M.
Corticosterone (A) and aldosterone (B) levels were significantly higher after 6 h of ELF-MF exposure. (C) Cyp11a1 andCyp11b2mRNA levels showed a
significant increase after 24 h of exposure to the ELF-MF as indicated by qRT-PCR results. (D) Secreted CYP11A1 protein levels were significantly
increased as indicated by western blotting. A representative blot image is shown (lanes 1 and 3: sham-exposed samples; lanes 2 and 4: ELF-MF- exposed
samples). Steroids were quantified twice per sample (culture dish), and qRT-PCR and western blotting were performed once. n = 8 each, *p < 0.05,
**p < 0.01 vs. sham exposure.
doi:10.1371/journal.pone.0154167.g001
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the adrenocorticotropic hormone (ACTH)-stimulated pathway and the angiotensin II-stimu-
lated pathway [16]. To determine which pathway is involved in ELF-MF-induced adrenal ste-
roidogenesis in Y-1 cells, we analyzed intracellular cAMP levels, CREB phosphorylation, and
[Ca2+]i after different periods of exposure to a 1.5-mT ELF-MF or sham treatment. cAMP lev-
els increased significantly over time (p< 0.0001). Exposure to ELF-MF for 1, 6, and 24 h
resulted in significantly higher cAMP levels than sham exposure for these periods (Fig 3A).
CREB phosphorylation was significantly higher upon exposure to ELF-MF than after sham
exposure for 24 h (Fig 3B). Conversely, intracellular Ca2+ levels were significantly lower after
24-h ELF-MF exposure than after sham treatment (Fig 3C). Taken together, these results indi-
cate that the PKA pathway is involved in ELF-MF-induced adrenal steroidogenesis in Y-1 cells.
Effects of NF449 treatment on cAMP concentration and PDE activity
after ELF-MF exposure
To clarify the mechanism underlying the ELF-MF-induced increase in intracellular cAMP lev-
els, we investigated the effect of NF449, a selective Gsα-subunit G-protein antagonist inhibiting
cAMP production, on the increase in cAMP resulting from 1.5-mT ELF-MF exposure and on
PDE activity in cells exposed to the ELF-MF for 6 h (Fig 4). NF449 inhibited the increase in the
cAMP concentration in Y-1 cells exposed to sham treatment and 1.5 mT ELF-MF for 24 h (p<
0.0001). However, the significant cAMP increase resulting from ELF-MF seen in the vehicle
control was preserved after treatment with 30 μMNF449 (Fig 4A). PDE activity did not change
between 6 h and 24 h of exposure time, but ELF-MF exposure significantly attenuated PDE
activity compared to that in sham-exposed cells at both 6 h and 24 h of exposure (Fig 4B).
These results indicate that the cAMP increase is caused by the attenuation of PDE activity.
Fig 2. Effects of ELF-MF and sham exposure on steroid secretion and enzyme expression in H295R cells. All data are presented as the mean ± S.E.
M. Cortisol (A) and aldosterone (B) secretion did not show a significant difference between sham and ELF-MF exposure. (C) After 24 h of ELF-MF and sham
exposure, mRNA expression of Star showed a significant increase in ELF-MF-exposed cells. (D) No significant increase was observed in protein levels. A
representative blot image is shown (lanes 1 and 3: sham-exposed sample; lanes 2 and 4: ELF-MF-exposed sample). Steroid levels were quantified twice per
sample (culture dish), and qRT-PCR and western blotting were performed once. n = 8 each, *p < 0.05, **p < 0.01.
doi:10.1371/journal.pone.0154167.g002
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Effect of 24-h ELF-MF exposure on corticosterone secretion depends on
the ELF-MF intensity
We additionally investigated whether the effect of 24-h ELF-MF exposure on corticosterone
secretion depended on ELF-MF intensity (Fig 5). The ratios relative to sham exposure (Fig 5B)
are also shown because of the change in absolute steroid secretion was significant (p< 0.0001,
Fig 5A). The effects of the ELF-MF were significant at intensities above 0.5 mT.
Discussion
We previously reported increased plasma adrenal steroid levels in mice exposed to an ELF-MF
for 200 h, without enhancement of the hypothalamic–pituitary–adrenal axis [9]. Our present
results suggested that ELF-MF exposure stimulates adrenal steroidogenesis in the Y-1 cell line,
and they strongly support the hypothesis that the ELF-MF stimulates steroidogenesis directly
in the adrenal cortex, and not via the common stress response. The significant increase in
CYP11A1 (cholesterol side-chain cleavage cytochrome P450), a rate-limiting enzyme for ste-
roidogenesis [13, 14], may have contributed to this increased steroidogenesis.
Human adrenal cortex-derived H295R cells also showed some ELF-MF-triggered changes
such as increased mRNA expression of Star, a rate-limiting protein for steroidogenesis to facili-
tate the transport of cholesterol to the inner mitochondrial membrane [12]. However, protein
expression of StAR and various other adrenal steroid proteins was not significantly induced by
ELF-MF exposure. Non-standardized adrenal steroid concentrations and cell counts for each
cell line after both treatments are shown in S1 Fig. The non-standardized steroid secretion data
Fig 3. Intracellular cAMP concentration was estimated in Y-1 cells exposed to ELF-MF and sham
treatments. All data are presented as the mean ± S.E.M. (A) cAMP levels were significantly higher upon
exposure to a 1.5-mT ELF-MF than after sham exposure for all durations (n = 8 each). (B) CREB
phosphorylation was significantly higher in the ELF-MF group than in the sham group with 24 h of exposure
(n = 8 each). (C) The 340/380 nm emission Fura ratio, which indicates [Ca2+]i, was significantly lower in cells
exposed to 24-h ELF-MF treatment (n = 10) than in sham-exposed cells (n = 10). cAMP levels were
quantified twice per sample (dish). The Fura ratio was estimated once per sample. *p < 0.05, **p < 0.01,
***p < 0.001.
doi:10.1371/journal.pone.0154167.g003
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Fig 4. Effect of NF449 on the increase in cAMP concentration resulting from ELF-MF exposure. All data are presented as the mean ± S.E.M. (A) NF449
inhibited the increase in cAMP concentration in Y-1 cells exposed to sham treatment and 1.5 mT ELF-MF for 6 h; however, the cAMP-increasing effect of
ELF-MF was still significantly higher than that of the sham treatment after 30 μMNF449 treatment (n = 8 each). (B) PDE activity was significantly lower in
ELF-MF- than in sham-exposed Y-1 cells at both 6 h and 24 h (n = 4 each). cAMP and PDE were quantified twice per sample. *p < 0.05, **p < 0.01.
doi:10.1371/journal.pone.0154167.g004
Fig 5. Intensity-dependent effect of ELF-MF exposure on corticosterone secretion. All data are presented as the mean ± S.E.M. Y-1 cells were exposed
to ELF-MFs or sham (24-h duration), and the corticosterone concentration in the medium was estimated (n = 8 each). ELF-MF intensities were set 0.25, 0.5,
1.5, and 3 mT, and the corresponding sham exposure in each ELF-MF condition was performed simultaneously. The absolute values (A) and ratios relative
to sham exposure (B) are shown. The effect of the ELF-MF was significant at intensities above 0.5 mT. Steroids were quantified twice per sample (dish),
**p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0154167.g005
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also suggest that the effect in H295R cells is weaker than that in the Y-1 cells (S1B, S1C, S1E
and S1F Fig). However, various studies have reported that ELF-MF exposure increases cell pro-
liferation in vitro [17–19]. The ELF-MF had a negative, albeit non-significant, effect on the cell
count at all time points tested in Y-1 cells, whereas the effect in H295R cells varied for different
exposure times (S1A and S1D Fig). The difference in the effects on cell proliferation may have
visibly affected the amounts of adrenal steroids because the data of adrenal steroids were pre-
sented as concentration/cell count. However, the mechanisms underlying the different prolifer-
ative effects in mouse and human cells are unknown at present.
ELF-MF-induced adrenal steroidogenesis may activate the cAMP-protein kinase A (PKA)-
CREB phosphorylation pathway. This ACTH-stimulated pathway induces gene transcription
and synthesis of steroidogenic proteins [13, 14, 20–22]. We investigated the effect of NF449, an
inhibitor of the Gsα-subunit, on the increase in cAMP concentration resulting from ELF-MF
exposure and PDE activity in cells exposed to the ELF-MF to clarify the mechanism underlying
the ELF-MF-dependent increase in cAMP. Treatment with 30 μMNF449 decreased the cAMP
concentration in Y-1 cells exposed to sham and ELF-MF treatments; the cAMP-increasing
effect of the ELF-MF was preserved. Unexpectedly, the cAMP-increasing effect was weakened
by treatment with 10 μMNF449. NF449 is also known as a selective inhibitor of the P2X1
receptor at lower concentrations [23]. Although the P2X1 receptor has not been reported to be
expressed in the adrenal cortex [24], an antagonistic effect might affect this result. In contrast,
PDE activity significantly decreased in Y-1 cells exposed to the ELF-MF, which suggests that
the increase in intracellular cAMP concentration induced by ELF-MF exposure in Y-1 cells
resulted from a decrease in PDE activity, and not the activation of G protein-coupled receptors
(Fig 6).
Additionally, [Ca2+]i was unexpectedly significantly decreased in the cells exposed to the
ELF-MF. Although it is well known that increases in [Ca2+]i also trigger adrenal steroidogenesis
via the angiotensin II-stimulated protein kinase c pathway [16], this effect may be negligible, at
least in our study system. The exact mechanism underlying the decrease is unknown, but it
may involve feedback regulation in response to the increase in cAMP concentration. In support
of this hypothesis, Kaneda et al. [25] reported that PDE inhibitor treatment decreased [Ca2+]i
in guinea pig ileal longitudinal smooth muscle.
We were not able to determine why ELF-MF exposure inhibited PDE activity in this study.
One possible mechanism involves the extracellular-signal-regulated kinase (ERK) pathway. It
is known that the PDE4 family, a PDE subgroup, is phosphorylated by ERK2, resulting in a
decrease in cAMP-hydrolyzing activity [26]. Moreover, some early studies have reported
increased ERK activation upon ELF-MF exposure in vitro [14] and in planarian flatworms
[27]. PDE inhibition is a powerful pharmacological tool used for treatment of cardiac failure
[28] and erectile dysfunction [29]. It is known that the adrenal gland expresses PDE8, contrib-
uting to steroidogenesis [20–22]. If the PDE-inhibitory effect has subtype specificity, ELF-MF
exposure may possess potential for hypoadrenalism therapy. Further investigation is needed to
clarify the PDE inhibition mechanism and subtype specificity.
We additionally investigated whether the effect of ELF-MF exposure on corticosterone
secretion is intensity-dependent. The effect of the ELF-MF was significant at intensities above
0.5 mT. This intensity is above the reference level of 0.2 mT for general public exposure to a
60-Hz ELF-MF as proposed by the International Commission on Non-Ionizing Radiation Pro-
tection; however, it is below the reference level for occupational exposure, which is set at 1 mT
[30]. Our results obtained from the human-derived H295R cells suggest that the resistance in
humans against ELF-MF exposure is higher than that in mice. However, the possibility of
enhancement of adrenal steroid secretion by ELF-MF exposure in the case of occupational
exposure should be investigated in more detail.
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In conclusion, ELF-MF exposure stimulates adrenal steroidogenesis via an increase in intra-
cellular cAMP, which is caused by inhibition of PDE activity in mouse adrenal cortex-derived
Y-1 cells. The same mechanism may trigger the increase in adrenal steroid secretion in mice
observed in our previous study [9]. The impact of our findings on human health is currently
unclear because the data in this study were obtained from human-derived cell cultures. More
research regarding the influence of occupational exposure and the therapeutic potential of the
ELF-MF is required in the future.
Supporting Information
S1 Fig. Non-standardized adrenal steroid concentrations and cell counts in ELF-MF and
sham-exposed Y-1 and H295R cells. All data are presented as the mean ± S.E.M. (A) The
ELF-MF effects for cell counts were negative at all-time points in Y-1 cells, although not signifi-
cantly. (D) In contrast, H295R cells showed some variation among exposure times. In the 6-h
exposure, the cell count was lower in the ELF-MF group than in the sham group. Corticoste-
rone (B) and aldosterone (C) levels of Y-1 cells were significantly higher after 6 h of ELF-MF
exposure than in the sham group. However in H295R, no significant effect of ELF-MF was
observed for cortisol (E), and a significant effect on aldosterone secretion was noted only after
24 h of ELF-MF exposure (F). Cell counts and sampling of medium were performed for each
sample (culture dish). Steroids were quantified twice per sample. n = 8 each, p< 0.05,
p< 0.01, p<0.001.
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